TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-12-18
公報種別公開国際商標公報
国際登録番号1816403
国際登録日2024-08-27
区分第5類(薬剤),第42類(科学・技術),第44類(医療・農林業)
商品役務Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease.,Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; medical testing and clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid.,Medical services; healthcare services; pharmaceutical services; medical consulting services; advisory services relating to pharmaceuticals; consultancy and information services relating to pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical services in the field of oncology; pharmaceutical services in the field of ophthalmology; pharmaceutical services in the field of neurology; pharmaceutical services in the field of anti-infectives; pharmaceutical services in connection with respiratory disease; pharmaceutical services in connection with cardiovascular disease; pharmaceutical services in connection with metabolic disease; pharmaceutical services in connection with the treatment and/or prevention of viral infections; pharmaceutical services in connection with diagnostics and imaging; pharmaceutical services in connection with renal disease; pharmaceutical services in connection with gastrointestinal disease; pharmaceutical services in connection with muscular skeletal disease; information, consultancy and advisory services relating to the aforesaid.
基礎出願番号UK00004024691
基礎出願日2024-03-12
基礎出願国GB
出願人Bicycletx Limited
OCRテキスト
OCRテキスト2B
OCRについて
この商標をJ-PlatPatで参照する

関連商標

Alcon Inc.
TRYPTYR
7か月前
Biohaven Therapeutics Ltd.
REJUTRIA
1か月前
DAM Group UK International Limited
8 .***Dr.Frank's WeightLossClinic
2か月前
Hermes Arzneimittel GmbH
15日前
INTACT
INTACT REGENERATIVE
5か月前
DAEWOONG CO., LTD.
DAEWOONGPET
9か月前
BIG SHOT DEVELOPMENTS LTD.
BIGSHOT
9か月前
Merz Pharma GmbH & Co. KGaA
XEOMIN
7か月前
Bausch Health Ireland Limited
CABTREO
9か月前
LESAFFRE ET COMPAGNIE
1か月前
Novartis AG
ORSACUE
6か月前
REGENXBIO Inc.
NAVSUNLI
3か月前
Boehringer Ingelheim Vetmedica GmbH
SOLECTUS
4か月前
NUTRITIONAL WHOLESOME BLENDS PTY LTD
Blended. BYSARAH
2か月前
Perfect Care Distribution
Halova
8か月前
Swedencare AB (publ)
PRODEN
11か月前
個人
Gönrgy
8か月前
Evinature Ltd
15日前
OLIVIT Sp. z o.o.
osavi
5か月前
Aston Group Worldwide Ltd
INESSA
1か月前
個人
LuxatempMaxProtect
3か月前
RAUMEDIC AG
ThermMotion
9か月前
TerraPower, LLC
tpi TERRAPOWER ISOTOPES
4か月前
NOVO NORDISK HEALTH CARE AG
Omredify
1日前
Made By Brave Limited
2か月前
Dyne Therapeutics, Inc.
DYNETHERAPEUTICS
7か月前
ARROWHEAD PHARMACEUTICALS, INC.
REDEMPLO
8か月前
Alcon Inc.
TRIPTYR
7か月前
ZEALAND PHARMA A/S
OVOYO
9か月前
Premier Foods Group Limited
FUEL10K
9か月前
Beijing Compont Medical Devices Co., Ltd.
compont
1日前
ZEALAND PHARMA A/S
1か月前
NOVO NORDISK HEALTH CARE AG
Omlifda
1日前
RAUMEDIC AG
SILMotion
9か月前
Huang, Ke
21日前
Novo Nordisk A/S
Zilconyc
6か月前
続きを見る